在胰腺癌进展和转移中的miRNAs
Ellie T Y Mok1,2, Jessica L Chitty3,4, Thomas R Cox5,6
1Matrix & Metastasis Lab, Cancer Ecosystems Program, The Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
Clinical & experimental metastasis
|January 19, 2024
概括
微RNAs (miRNAs) 是细胞中的关键调节者,与癌症相关的改变表达. 本综述探讨了miRNA在胰腺管腺癌 (PDAC) 中的作用,用于新的诊断和治疗方法.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 微RNAs (miRNAs) 是小型非编码RNAs,对于调节真核细胞中的基因表达至关重要.
- 毫米RNA表达的失调与包括癌症在内的各种疾病有关,它们可以作为瘤抑制剂或促进剂.
- 胰腺管腺癌 (PDAC) 是一种致命的癌症,诊断和治疗选择有限,由显著的遗传突变驱动.
研究的目的:
- 审查miRNAs在胰腺管道腺癌 (PDAC) 发病和进展中的多方面的作用.
- 阐明miRNAs在下游信号通路中的参与,这对于PDAC发展至关重要.
- 总结miRNAs作为PDAC中的诊断,预后和治疗工具的当前和潜在应用.
主要方法:
- 关于专注于癌症中miRNA功能,特别是PDAC的科学文章的文献评论.
- 对调查miRNA与PDAC驱动基因突变相互作用的研究进行分析.
- 对基于miRNA的治疗策略和PDAC的诊断/预后生物标志物的研究综合.
主要成果:
- miRNAs在PDAC中起着复杂的作用,通过与关键遗传驱动器的相互作用影响瘤的启动和进展.
- 特定的miRNAs参与调节PDAC中涉及的关键下游信号通路.
- miRNAs作为早期检测的生物标志物和PDAC治疗的治疗点具有前景.
结论:
- 了解miRNAs和PDAC进展之间的复杂关系对于开发新的临床策略至关重要.
- miRNAs代表了改善诊断准确性,患者预后和胰腺癌治疗疗效的有希望的途径.
- 准miRNA路径为抗击PDAC的创新治疗提供了潜在的潜力.
相关概念视频
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K